Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression.

Sillars-Hardebol AH, Carvalho B, Beliën JA, de Wit M, Delis-van Diemen PM, Tijssen M, van de Wiel MA, Pontén F, Meijer GA, Fijneman RJ.

Cell Oncol (Dordr). 2012 Aug;35(4):293-300. doi: 10.1007/s13402-012-0088-2. Epub 2012 Jun 19.

PMID:
22711543
2.

Congenital genetic instability in colorectal carcinomas.

Svendsen LB.

Dan Med Bull. 1993 Nov;40(5):546-56. Review.

PMID:
8299399
3.

Wnt signalling pathway in the serrated neoplastic pathway of the colorectum: possible roles and epigenetic regulatory mechanisms.

Fu X, Li L, Peng Y.

J Clin Pathol. 2012 Aug;65(8):675-9. doi: 10.1136/jclinpath-2011-200602. Epub 2012 Mar 12. Review.

PMID:
22412046
4.

Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosis.

Tai CJ, Hsu CH, Shen SC, Lee WR, Jiang MC.

J Exp Clin Cancer Res. 2010 Aug 11;29:110. doi: 10.1186/1756-9966-29-110. Review.

5.

CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.

Jiang MC.

Tumour Biol. 2016 Oct;37(10):13077-13090. Epub 2016 Sep 5. Review.

PMID:
27596143
6.

Mitotic crossover--an evolutionary rudiment which promotes carcinogenesis of colorectal carcinoma.

Rovcanin B, Ivanovski I, Djuric O, Nikolic D, Petrovic J, Ivanovski P.

World J Gastroenterol. 2014 Sep 21;20(35):12522-5. doi: 10.3748/wjg.v20.i35.12522. Review.

7.

Expression and genomic profiling of colorectal cancer.

Cardoso J, Boer J, Morreau H, Fodde R.

Biochim Biophys Acta. 2007 Jan;1775(1):103-37. Epub 2006 Aug 22. Review.

PMID:
17010523

Supplemental Content

Support Center